NEUP: Neuphoria Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Neuphoria Therapeutics Inc (NEUP).
$8.20M Market Cap.
NEUP Market Cap. (MRY)
NEUP Shares Outstanding (MRY)
NEUP Assets (MRY)
Total Assets
$27.65M
Total Liabilities
$10.16M
Total Investments
$0
NEUP Income (MRY)
Revenue
$0
Net Income
-$15.49M
Operating Expense
$17.89M
NEUP Cash Flow (MRY)
CF Operations
-$14.68M
CF Investing
$0
CF Financing
$15.11M
NEUP Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $27,649,093 (-3.20%) | $28,562,948 (-56.27%) | $65,310,172 (20.36%) | $54,263,445 (57.45%) |
Assets Current | $13,193,758 (-1.00%) | $13,326,612 (-68.13%) | $41,810,246 (35.19%) | $30,927,004 (271.14%) |
Assets Non-Current | $14,455,335 (-5.13%) | $15,236,336 (-35.16%) | $23,499,926 (0.70%) | $23,336,441 (-10.69%) |
Goodwill & Intangible Assets | $14,157,540 (-4.50%) | $14,824,439 (-34.71%) | $22,706,396 (1.61%) | $22,346,498 (-9.30%) |
Shareholders Equity | $17,490,372 (-20.54%) | $22,010,563 (-61.33%) | $56,912,854 (19.57%) | $47,597,537 (275.32%) |
Property Plant & Equipment Net | $218,969 (-34.24%) | $333,000 (-50.63%) | $674,530 (-22.55%) | $870,943 (-17.44%) |
Cash & Equivalents | $12,686,935 (4.15%) | $12,181,944 (-63.71%) | $33,564,857 (17.77%) | $28,499,449 (522.56%) |
Accumulated Other Comprehensive Income | -$3,013,595 (1.48%) | -$3,058,783 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $119,000 (-78.54%) | $554,640 (27.16%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $435,640 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $119,000 (0.00%) | $119,000 (-72.72%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $126,884 (-70.22%) | $426,087 (562.04%) | $64,360 (-67.85%) | $200,212 (237.68%) |
Trade & Non-Trade Payables | $2,243,662 (55.89%) | $1,439,291 (-48.34%) | $2,786,280 (53.57%) | $1,814,390 (-6.01%) |
Accumulated Retained Earnings (Deficit) | -$177,977,071 (-9.53%) | -$162,484,905 (6.24%) | -$173,306,503 (-12.51%) | -$154,040,501 (-3.46%) |
Tax Assets | $0 (0%) | $0 (0%) | $6,719,761 (624.06%) | $928,073 (-68.21%) |
Tax Liabilities | $963,540 (-12.62%) | $1,102,713 (-38.69%) | $1,798,625 (-2.37%) | $1,842,303 (-16.39%) |
Total Debt | $239,618 (-32.27%) | $353,765 (-49.00%) | $693,623 (-20.07%) | $867,841 (-92.91%) |
Debt Current | $121,990 (7.07%) | $113,930 (-28.81%) | $160,040 (-8.14%) | $174,218 (-97.07%) |
Debt Non-Current | $117,628 (-50.95%) | $239,835 (-55.05%) | $533,583 (-23.07%) | $693,623 (-88.96%) |
Total Liabilities | $10,158,721 (55.04%) | $6,552,385 (-21.97%) | $8,397,318 (25.97%) | $6,665,908 (-69.40%) |
Liabilities Current | $3,829,073 (39.81%) | $2,738,788 (-18.38%) | $3,355,640 (42.16%) | $2,360,544 (-71.46%) |
Liabilities Non-Current | $6,329,648 (65.98%) | $3,813,597 (-24.36%) | $5,041,678 (17.10%) | $4,305,364 (-68.13%) |
NEUP Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $263,634 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $8,474,591 (-4.90%) | $8,911,271 (-21.82%) | $11,397,852 (57.00%) | $7,259,550 (15.46%) |
Research & Development Expense | $9,417,785 (-27.95%) | $13,071,705 (-18.30%) | $15,998,999 (177.65%) | $5,762,303 (-1.12%) |
Operating Expenses | $17,892,376 (-18.61%) | $21,982,976 (-19.76%) | $27,396,851 (110.39%) | $13,021,853 (7.48%) |
Interest Expense | $0 (0%) | $0 (0%) | $44,165 (-96.94%) | $1,443,885 (-21.80%) |
Income Tax Expense | -$87,320 (37.26%) | -$139,174 (27.44%) | -$191,808 (-2.34%) | -$187,427 (9.72%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$15,492,166 (27.54%) | -$21,381,677 (1.74%) | -$21,759,358 (-150.19%) | -$8,697,037 (-22.18%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$15,492,166 (27.54%) | -$21,381,677 (1.74%) | -$21,759,358 (-150.19%) | -$8,697,037 (-22.18%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$15,492,166 (27.54%) | -$21,381,677 (1.74%) | -$21,759,358 (-150.19%) | -$8,697,037 (-22.18%) |
Weighted Average Shares | $832,225 (22.39%) | $679,970 (12.16%) | $606,276 (0.80%) | $601,480 |
Weighted Average Shares Diluted | $832,225 (22.39%) | $679,970 | - | - |
Earning Before Interest & Taxes (EBIT) | -$15,579,486 (27.61%) | -$21,520,851 (1.76%) | -$21,907,001 (-194.43%) | -$7,440,579 (-35.79%) |
Gross Profit | $0 (0%) | $0 (0%) | $263,634 (0%) | $0 (0%) |
Operating Income | -$17,892,376 (18.61%) | -$21,982,976 (18.98%) | -$27,133,217 (-108.37%) | -$13,021,853 (-7.90%) |
NEUP Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | $0 (0%) | $621,703 (875.13%) | -$80,206 (58.90%) |
Net Cash Flow from Financing | $15,108,794 (291.58%) | $3,858,451 (-85.71%) | $26,995,622 (-14.45%) | $31,553,706 (689.02%) |
Net Cash Flow from Operations | -$14,680,777 (-0.29%) | -$14,637,720 (32.72%) | -$21,755,487 (-188.58%) | -$7,538,724 (-93.14%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $428,017 (103.97%) | -$10,779,269 (-283.89%) | $5,861,838 (-75.51%) | $23,934,776 (353.13%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $435,640 (467.73%) | -$118,466 (-123.80%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $173,547 (407.95%) | $34,166 (-86.69%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | -$174,218 (98.53%) | -$11,866,946 (-43.20%) |
Issuance (Purchase) of Equity Shares | $15,108,794 (291.58%) | $3,858,451 (-88.27%) | $32,890,463 (-24.97%) | $43,836,131 (1244.67%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $76,974 (131.57%) | -$243,822 (69.39%) | -$796,430 (-5991.71%) | -$13,074 (-127.46%) |
Share Based Compensation | $814,808 (-39.43%) | $1,345,309 (0%) | $0 (0%) | $0 (0%) |
Depreciation Amortization & Accretion | $662,991 (-0.03%) | $663,192 (0%) | $0 (0%) | $0 (0%) |
NEUP Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | - | - | 100.00% | - |
Profit Margin | - | - | -8253.60% | - |
EBITDA Margin | - | - | -8309.60% | - |
Return on Average Equity (ROAE) | -78.40% (-44.65%) | -54.20% (-30.29%) | -41.60% (-43.94%) | -28.90% |
Return on Average Assets (ROAA) | -55.10% (-20.83%) | -45.60% (-25.27%) | -36.40% (-85.71%) | -19.60% |
Return on Sales (ROS) | - | - | -8309.60% | - |
Return on Invested Capital (ROIC) | 862.30% (211.16%) | -775.70% (-46.97%) | -527.80% (-295.06%) | -133.60% |
Dividend Yield | 0% (0%) | 0% (0%) | 0% | - |
Price to Earnings Ratio (P/E) | -0.64 (27.88%) | -0.89 (65.15%) | -2.54 | - |
Price to Sales Ratio (P/S) | - | - | 277.77 | - |
Price to Book Ratio (P/B) | 0.7 (-40.57%) | 1.18 (-8.08%) | 1.29 | - |
Debt to Equity Ratio (D/E) | 0.58 (94.97%) | 0.3 (101.35%) | 0.15 (5.71%) | 0.14 (-91.85%) |
Earnings Per Share (EPS) | -21.6 (50.00%) | -43.2 (9.09%) | -47.52 (-100.00%) | -23.76 (0.00%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0.3 (0%) | 0 |
Free Cash Flow Per Share (FCFPS) | -17.64 (18.06%) | -21.53 (39.53%) | -35.6 (-185.31%) | -12.48 |
Book Value Per Share (BVPS) | 21.02 (-35.08%) | 32.37 (-65.52%) | 93.87 (18.63%) | 79.13 |
Tangible Assets Book Value Per Share (TABVPS) | 16.21 (-19.77%) | 20.2 (-71.25%) | 70.27 (32.43%) | 53.06 |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | -1 | - |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.06 (-71.65%) | 0.19 (113.32%) | -1.46 | - |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 |
Current Ratio | 3.45 (-29.18%) | 4.87 (-60.95%) | 12.46 (-4.90%) | 13.1 (1201.09%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$14,680,777 (-0.29%) | -$14,637,720 (32.18%) | -$21,581,940 (-187.58%) | -$7,504,558 (-105.80%) |
Enterprise Value (EV) | -$544,718 (80.52%) | -$2,796,242 (-112.61%) | $22,171,397 | - |
Earnings Before Tax (EBT) | -$15,579,486 (27.61%) | -$21,520,851 (1.96%) | -$21,951,166 (-147.07%) | -$8,884,464 (-21.27%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$14,916,495 (28.48%) | -$20,857,659 (4.79%) | -$21,907,001 (-194.43%) | -$7,440,579 (-35.79%) |
Invested Capital | -$2,784,837 (-236.15%) | -$828,458 (-112.99%) | $6,376,902 (231.30%) | $1,924,795 (-79.10%) |
Working Capital | $9,364,685 (-11.55%) | $10,587,824 (-72.47%) | $38,454,606 (34.61%) | $28,566,460 (46890.49%) |
Tangible Asset Value | $13,491,553 (-1.80%) | $13,738,509 (-67.75%) | $42,603,776 (33.48%) | $31,916,947 (224.89%) |
Market Capitalization | $8,201,826 (-54.31%) | $17,951,218 (-64.70%) | $50,854,474 | - |
Average Equity | $19,750,468 (-49.95%) | $39,461,708 (-24.48%) | $52,255,196 (73.38%) | $30,139,772 |
Average Assets | $28,106,020 (-40.12%) | $46,936,560 (-21.49%) | $59,786,808 (34.77%) | $44,363,150 |
Invested Capital Average | -$1,806,648 (-165.12%) | $2,774,222 (-33.16%) | $4,150,848 (-25.45%) | $5,568,138 |
Shares | 891,115 (31.05%) | 679,970 (12.16%) | 606,276 (0.80%) | 601,480 |